|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and equivalents | ||||||||||||||||||||
| Debt securities (Note 3) | ||||||||||||||||||||
| Loan receivables | ||||||||||||||||||||
| Unsecuritized loans held for investment | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total loan receivables | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total less: Allowance for credit losses | ||||||||||||||||||||
| Loan receivables, net | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total loan receivables, net | ||||||||||||||||||||
| Loan receivables held for sale (Note 5) | ||||||||||||||||||||
| Total loan receivables held for sale (Note 5) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets (Note 6) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total other assets (Note 6) | ||||||||||||||||||||
| Assets held for sale (Note 3) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Deposits: (Note 7) | ||||||||||||||||||||
| Interest-bearing deposit accounts | ||||||||||||||||||||
| Non-interest-bearing deposit accounts | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings: (Notes 5 and 8) | ||||||||||||||||||||
| Borrowings of consolidated securitization entities | ||||||||||||||||||||
| Senior and subordinated unsecured notes | ||||||||||||||||||||
| Total borrowings | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock, par value $0.001 per share; 300 million shares authorized, 1.26 million and 1.25 million shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively (Note 12) | ||||||||||||||||||||
| Common stock, par value $0.001 per share; 4.0 billion shares authorized; 834 million shares issued at both September 30, 2026 and December 31, 2025; 311 million and 347 million shares outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss): | ||||||||||||||||||||
| Debt securities | ||||||||||||||||||||
| Currency translation adjustments | ||||||||||||||||||||
| Employee benefit plans and other | ||||||||||||||||||||
| Treasury stock, at cost; 523 million and 487 million shares at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Preferred stock outstanding (in shares) | ||||||||||||||||||||
| Preferred stock issued (in shares) | ||||||||||||||||||||
Loading...
